| abstract |
A safe dose of a double V region antibody-like binding protein or fragment thereof, and a method for assessing the binding of a double V region antibody-like protein or fragment thereof to their target, and a double V region antibody-like binding protein or Disclosed herein is a method of treating idiopathic pulmonary fibrosis (IPF) by administering a safe dose of the fragment. In some embodiments, the double V region antibody-like binding protein or fragment thereof binds to both IL-4 and IL-13. |